{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:05:43Z","timestamp":1792757143477,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Unitaid","award":["22-AWD-024"],"award-info":[{"award-number":["22-AWD-024"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim was to assess point-in-time stock availability and pricing of drugs used for postpartum haemorrhage management (oxytocin, misoprostol, heat-stable carbetocin and tranexamic acid (TXA)).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional point-in-time survey using an adapted version of the WHO\/Health Action International methodology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>In public, for-profit and not-for-profit private health facilities and in pharmacies in the Democratic Republic of the Congo (DRC), India and Kenya.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>211 health facilities in the DRC (n=63), India (n=76) and Kenya (n=72).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Primary and secondary outcome measures<\/jats:title>\n                  <jats:p>Availability was calculated as a mean percentage of facility types where each medicine was observed on the day of data collection. Average procurement prices were calculated by obtaining the current purchase price per drug at each facility and then averaging prices across all facility types.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Availability of the four medicines was limited, and only oxytocin in the DRC met the WHO\u2019s benchmark of 80%. Across all countries, availability of oxytocin, misoprostol and TXA was lower in public health facilities than in other facility types, indicating an important gap. Where the four medicines were available, non-quality-assured products were predominant across the three countries. The average facility procurement prices in India and Kenya were reported to be lower than those in the DRC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Availability of oxytocin, misoprostol, heat-stable carbetocin and TXA was suboptimal and varied by facility type and geography, and similar trends were found across the four drugs. This indicates that access strategies should be tailored to each drug, geographical area and facility type. Strategies to improve commodity access in public-sector facilities will be especially important, as well as improving the availability of quality-assured products, possibly through value-based procurement practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095521","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:15:20Z","timestamp":1758165320000},"page":"e095521","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Access to oxytocin, misoprostol, heat-stable carbetocin and tranexamic acid for management of postpartum haemorrhage in the Democratic Republic of the Congo, India and Kenya: a cross-sectional survey of drug availability and pricing"],"prefix":"10.1136","volume":"15","author":[{"given":"Mutsumi","family":"Metzler","sequence":"first","affiliation":[{"name":"PATH, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtuza","family":"Stationwala","sequence":"additional","affiliation":[{"name":"PATH, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mukumbayi","sequence":"additional","affiliation":[{"name":"PATH, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kibonge","sequence":"additional","affiliation":[{"name":"PATH, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Doi","sequence":"additional","affiliation":[{"name":"Jhpiego Corporation, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-0910","authenticated-orcid":false,"given":"Patricia","family":"Coffey","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2025091720150951000_15.9.e095521.1","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","article-title":"Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis","volume":"13","author":"Cresswell","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2025091720150951000_15.9.e095521.2","unstructured":"World Health Organization . WHO issues global plan to tackle leading cause of death in childbirth. 2023. Available: https:\/\/www.who.int\/news\/item\/11-10-2023-who-issues-global-plan-to-tackle-leading-cause-of-death-in-childbirth"},{"key":"2025091720150951000_15.9.e095521.3","unstructured":"World Health Organization . Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division, 2023. Available: https:\/\/iris.who.int\/handle\/10665\/366225"},{"key":"2025091720150951000_15.9.e095521.4","unstructured":"Integrated African Health Observatory, World Health Organization . Maternal mortality: The urgency of a systemic and multisectoral approach in mitigating maternal deaths in Africa, 2023. Available: https:\/\/files.aho.afro.who.int\/afahobckpcontainer\/production\/files\/iAHO_Maternal_Mortality_Regional_Factsheet.pdf"},{"key":"2025091720150951000_15.9.e095521.5","unstructured":"World Health Organization . WHO recommendations: uterotonics for the prevention of postpartum haemorrhage, 2018. Available: https:\/\/iris.who.int\/handle\/10665\/277276"},{"key":"2025091720150951000_15.9.e095521.6","unstructured":"World Health Organization . WHO Recommendation on tranexamic acid for the treatment of postpartum haemorrhage, 2017. Available: https:\/\/iris.who.int\/handle\/10665\/259374"},{"key":"2025091720150951000_15.9.e095521.7","unstructured":"World Health Organization . WHO recommendations on the assessment of postpartum blood loss and treatment bundles for postpartum haemorrhage, 2023. Available: https:\/\/iris.who.int\/handle\/10665\/375231"},{"key":"2025091720150951000_15.9.e095521.8","unstructured":"World Health Organization . Medicines (Finished Pharmaceutical Products\/Biotherapeutic products) \u2013 Prequalification, Available: https:\/\/extranet.who.int\/prequal\/medicines\/prequalified\/finished-pharmaceutical-products"},{"key":"2025091720150951000_15.9.e095521.9","unstructured":"World Health Organization & Health Action International . Measuring medicine prices, availability, affordability and price components. 2nd edn.2008. Available: https:\/\/iris.who.int\/handle\/10665\/70013"},{"key":"2025091720150951000_15.9.e095521.10","unstructured":"Kenya National Bureau of Statistics. 2022 . 2019 Kenya Population and Housing Census: Analytical Report on Population Dynamics, Volume VIII, 2022. Available: https:\/\/www.knbs.or.ke\/wp-content\/uploads\/2024\/05\/2019-Kenya-Population-and-Housing-Census-Analytical-Report-on-Population-Dynamics-Vol-VIII.pdf"},{"key":"2025091720150951000_15.9.e095521.11","unstructured":"World Health Organization . A roadmap to combat postpartum haemorrhage between 2023 and 2030. 2023. Available: https:\/\/iris.who.int\/handle\/10665\/373221"},{"key":"2025091720150951000_15.9.e095521.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042948"},{"key":"2025091720150951000_15.9.e095521.13","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)00693-6","article-title":"Hope for access to abortion in Kenya","volume":"399","author":"Makoni","year":"2022","journal-title":"Lancet"},{"key":"2025091720150951000_15.9.e095521.14","unstructured":"India ministry of health and family welfare press release (april 27, 2018). regulation of manufacture, sale and import of oxytocin in india. 2025. Available: https:\/\/www.pib.gov.in\/PressReleaseIframePage.aspx?PRID=1530592"},{"key":"2025091720150951000_15.9.e095521.15","unstructured":"Center for Reproductive Rights . Factsheet: The Medical Termination Of Pregnancy (Amendment) Act, 2021. 2022. Available: https:\/\/reproductiverights.org\/wp-content\/uploads\/2022\/09\/India-FACTSHEET-MTP-Amendment-Act-9-22.pdf"},{"key":"2025091720150951000_15.9.e095521.16","unstructured":"Availability of Medical Abortion Drugs in the Markets of Six Indian States, 2020. 2020. Available: https:\/\/pratigyacampaign.org\/wp-content\/uploads\/2020\/09\/availability-of-medical-abortion-drugs-frhs-india-report-state-factsheets-delhi-web-version.pdf"},{"key":"2025091720150951000_15.9.e095521.17","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.010402","article-title":"Availability of brands of six essential medicines in 124 pharmacies in Maharashtra","volume":"8","author":"Millard","year":"2018","journal-title":"J Glob Health"},{"key":"2025091720150951000_15.9.e095521.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-014-0386-y"},{"key":"2025091720150951000_15.9.e095521.19","unstructured":"Kenya Ministry of Health . Kenya Household Health Expenditure and Utilization Survey, 2018. Available: https:\/\/statistics.knbs.or.ke\/nada\/index.php\/catalog\/95"},{"key":"2025091720150951000_15.9.e095521.20","unstructured":"Reproductive Health Supplies Coalition, Landscape and Projection of Reproductive Health Supply Needs . Maternal Health: Overview Report for Low- and Middle-Income Countries, 2024. Available: https:\/\/leap.rhsupplies.org\/maternal-health\/overview"},{"key":"2025091720150951000_15.9.e095521.21","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.25259\/IJMA_34_2024","article-title":"Integrating Heat-Stable Carbetocin and Tranexamic Acid for Prevention and Management of Postpartum Hemorrhage in Sub-Saharan Africa: A Five-Country Pilot Implementation Study","volume":"13","author":"Rushwan","year":"2024","journal-title":"Int J MCH AIDS"},{"key":"2025091720150951000_15.9.e095521.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-2810-9","article-title":"Quality, availability and storage conditions of oxytocin and misoprostol in Malawi","volume":"20","author":"Hagen","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025091720150951000_15.9.e095521.23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd013795.pub2"},{"key":"2025091720150951000_15.9.e095521.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10459-x","article-title":"Influence of inventory management practices on the availability of emergency obstetric drugs in Rwandan public hospitals: a case of Rwanda Southern Province","volume":"24","author":"Kabera","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2025091720150951000_15.9.e095521.25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hpm.3910","article-title":"Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States-A Supply Chain Perspective","volume":"40","author":"Ajima","year":"2025","journal-title":"Int J Health Plann Manage"},{"key":"2025091720150951000_15.9.e095521.26","doi-asserted-by":"crossref","DOI":"10.2196\/58577","article-title":"Improving Access to and Delivery of Maternal Health Care Services to Prevent Postpartum Hemorrhage in Selected States in Nigeria: Human-Centered Design Study","volume":"12","author":"Tijani","year":"2025","journal-title":"JMIR Hum Factors"},{"key":"2025091720150951000_15.9.e095521.27","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.25259\/IJMA_11_2023","article-title":"Introduction of Heat-Stable Carbetocin through a Public-Private Partnership Model in India: A Retrospective Study to Determine Feasibility and Its Optimal Use in Public Health Settings","volume":"13","author":"Alwadhi","year":"2024","journal-title":"Int J MCH AIDS"},{"key":"2025091720150951000_15.9.e095521.28","first-page":"S9","article-title":"A Tale of Two Medicines: The Need for Ownership, End-to-End Planning and Execution for Development and Introduction of Maternal Health Medicines","volume":"13","author":"G\u00fclmezoglu","year":"2024","journal-title":"Int J MCH AIDS"},{"key":"2025091720150951000_15.9.e095521.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-019-2512-3","article-title":"Value based maternal and newborn care requires alignment of adequate resources with high value activities","volume":"19","author":"De Jonge","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025091720150951000_15.9.e095521.30","unstructured":"US Pharmacopeial Convention, Reproductive Health Supplies Coalition . Manufacturing landscape assessment for maternal health supplies in sub-saharan africa. 2024. Available: https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/global-public-health\/compass-maternal-health-supplies-report_final.pdf"},{"key":"2025091720150951000_15.9.e095521.31","unstructured":"Kenya National Health Insurance Fund . Linda mama program page, Available: https:\/\/www.nhif.or.ke\/linda-mama-hospitals\/"},{"key":"2025091720150951000_15.9.e095521.32","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3298"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:15:29Z","timestamp":1758165329000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-095521"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095521","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}